pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
LYGLIV-0001
Liver Diseases
LyGenesis Inc
0
catalysts
Phase 1
LYL-273
Metastatic Colorectal Cancer
$LYEL
Lyell Immunopharma, Inc.
0
catalysts
Phase 2
LYT-200
Liver Cancer
Gallop Oncology Inc
0
catalysts
Phase 1
LZ-001
← prev
page 105 of 231
next →
131
Pain
89
Neurology
1
Non-Small Cell Lung Cancer
Livzon Pharmaceutical Group Inc
0
catalysts
pre_registration
Lagevrio
Lagevrio (molnupiravir)
Coronavirus Disease 2019 (COVID-19)
$MRK
Merck & Co., Inc.
0
catalysts
Preclinical
Lead Candidate
Parkinson's Disease
MaavRx Ltd
0
catalysts
Preclinical
Lead Program
Corneal Degeneration
2A Biosciences Inc
0
catalysts
Marketed
Lialda ER
Lialda (mesalamine)
Ulcerative Colitis
Takeda Pharmaceuticals USA Inc
0
catalysts
pre_registration
LipidRescue
Drug Toxicity
ResQ Pharma Inc
0
catalysts
Marketed
Lopimune
Lopinavir + Ritonavir ((lopinavir + ritonavir))
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Cipla USA Inc
0
catalysts
Marketed
Loseasonique
Loseasonique (ethinylestradiol + levonorgestrel)
Female Contraception
Teva Pharmaceuticals USA Inc
0
catalysts
Marketed
Lotensin HCT
Benazepril Hydrochloride + Hydrochlorothiazide + Rising ((benazepril hydrochloride + hydrochlorothiazide [INN]))
Hypertension
Rising Pharma Holdings Inc
0
catalysts
Marketed
Lumizyme
Lumizyme (alglucosidase alfa)
Pompe Disease
Genzyme Corp
0
catalysts
Phase 2
Lyophilized Microbiota
Mutational Disorders
Gut-Brain Axis Therapeutics LLC
0
catalysts
Preclinical
Lysosomal Storage Disorder (Undisclosed)
Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome )
Esteve Pharmaceuticals SA
0
catalysts
Marketed
Lyumjev
Lyumjev (insulin lispro-aabc)
Type 1 Diabetes (Juvenile Diabetes)
Eli Lilly and Co
0
catalysts
Preclinical
M-002
Inherited Metabolic Disorders
M6P Therapeutics Inc
0
catalysts
Preclinical
M-011
Gaucher Disease
M6P Therapeutics Inc
0
catalysts
Preclinical
M-012
Gaucher Disease Type I
M6P Therapeutics Inc
0
catalysts
Preclinical
M-021
Pompe Disease
M6P Therapeutics Inc
0
catalysts
Phase 2
M-032
Anaplastic Astrocytoma
UAB Minority Health and Health Equity Research Center
0
catalysts
Preclinical
M-102
Amyotrophic Lateral Sclerosis
Aclipse Therapeutics LLC
0
catalysts
Preclinical
M-9i
Acute Ischemic Stroke
Translational Sciences Inc
0
catalysts
MAGNESIUM SULFATE IN 5% DEXTROSE
MAGNESIUM SULFATE IN 5% DEXTROSE (MAGNESIUM SULFATE HEPTAHYDRATE)
FRESENIUS KABI USA
0
catalysts
Phase 2
MAI-001
Depression
Nanjing Mainowei Pharmaceutical Technology Co Ltd.
0
catalysts
MANGANESE
MANGANESE (MANGANESE)
FRESENIUS KABI USA
0
catalysts
Phase 2
MANP
Resistant Hypertension
E-Star BioTech LLC
0
catalysts
Preclinical
MAR-001-HLE
Hypertriglyceridemia
Marea Therapeutics Inc
0
catalysts
MARCAINE SPINAL
MARCAINE SPINAL (BUPIVACAINE HYDROCHLORIDE IN DEXTROSE)
HOSPIRA
0
catalysts
Preclinical
MAb AR9.6
Pancreatic Cancer
OncoCare Therapeutics Inc
0
catalysts
